Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1942 1
1943 1
1944 1
1946 2
1947 2
1948 5
1949 2
1950 1
1951 3
1953 4
1954 3
1955 2
1956 3
1957 4
1958 2
1959 5
1960 2
1961 7
1962 3
1963 3
1964 11
1965 13
1966 6
1967 2
1968 2
1969 2
1970 1
1971 2
1972 1
1973 2
1974 5
1975 2
1976 7
1977 6
1978 12
1979 18
1980 14
1981 17
1982 13
1983 27
1984 19
1985 17
1986 33
1987 14
1988 25
1989 27
1990 38
1991 27
1992 16
1993 24
1994 28
1995 36
1996 26
1997 21
1998 17
1999 35
2000 27
2001 23
2002 30
2003 27
2004 20
2005 28
2006 36
2007 38
2008 40
2009 41
2010 57
2011 49
2012 47
2013 46
2014 59
2015 65
2016 64
2017 70
2018 79
2019 73
2020 86
2021 128
2022 119
2023 98
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

1,817 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Multiple Sclerosis.
Cross A, Riley C. Cross A, et al. Continuum (Minneap Minn). 2022 Aug 1;28(4):1025-1051. doi: 10.1212/CON.0000000000001170. Continuum (Minneap Minn). 2022. PMID: 35938656 Review.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. Among authors: cross ah. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Zoonoses under our noses.
Cross AR, Baldwin VM, Roy S, Essex-Lopresti AE, Prior JL, Harmer NJ. Cross AR, et al. Microbes Infect. 2019 Jan-Feb;21(1):10-19. doi: 10.1016/j.micinf.2018.06.001. Epub 2018 Jun 18. Microbes Infect. 2019. PMID: 29913297 Free PMC article. Review.
Pregabalin.
Cross AL, Viswanath O, Sherman AL. Cross AL, et al. 2022 Nov 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2022 Nov 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29261857 Free Books & Documents.
American Association for the Surgery of Trauma/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma.
Yorkgitis BK, Berndtson AE, Cross A, Kennedy R, Kochuba MP, Tignanelli C, Tominaga GT, Jacobs DG, Marx WH, Ashley DW, Ley EJ, Napolitano L, Costantini TW. Yorkgitis BK, et al. Among authors: cross a. J Trauma Acute Care Surg. 2022 Mar 1;92(3):597-604. doi: 10.1097/TA.0000000000003475. J Trauma Acute Care Surg. 2022. PMID: 34797813
Mitigation translocation as a management tool.
Bradley HS, Tomlinson S, Craig MD, Cross AT, Bateman PW. Bradley HS, et al. Among authors: cross at. Conserv Biol. 2022 Feb;36(1):e13667. doi: 10.1111/cobi.13667. Epub 2021 Feb 9. Conserv Biol. 2022. PMID: 33210780 Review.
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.
Bull CJ, Bell JA, Murphy N, Sanderson E, Davey Smith G, Timpson NJ, Banbury BL, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Casey G, Castellví-Bel S, Chan AT, Chang-Claude J, Cross AJ, de la Chapelle A, Figueiredo JC, Gallinger SJ, Gapstur SM, Giles GG, Gruber SB, Gsur A, Hampe J, Hampel H, Harrison TA, Hoffmeister M, Hsu L, Huang WY, Huyghe JR, Jenkins MA, Joshu CE, Keku TO, Kühn T, Kweon SS, Le Marchand L, Li CI, Li L, Lindblom A, Martín V, May AM, Milne RL, Moreno V, Newcomb PA, Offit K, Ogino S, Phipps AI, Platz EA, Potter JD, Qu C, Quirós JR, Rennert G, Riboli E, Sakoda LC, Schafmayer C, Schoen RE, Slattery ML, Tangen CM, Tsilidis KK, Ulrich CM, van Duijnhoven FJB, van Guelpen B, Visvanathan K, Vodicka P, Vodickova L, Wang H, White E, Wolk A, Woods MO, Wu AH, Campbell PT, Zheng W, Peters U, Vincent EE, Gunter MJ. Bull CJ, et al. Among authors: cross aj. BMC Med. 2020 Dec 17;18(1):396. doi: 10.1186/s12916-020-01855-9. BMC Med. 2020. PMID: 33327948 Free PMC article.
Ecosystem Restoration: A Public Health Intervention.
Breed MF, Cross AT, Wallace K, Bradby K, Flies E, Goodwin N, Jones M, Orlando L, Skelly C, Weinstein P, Aronson J. Breed MF, et al. Among authors: cross at. Ecohealth. 2021 Sep;18(3):269-271. doi: 10.1007/s10393-020-01480-1. Epub 2020 Jun 23. Ecohealth. 2021. PMID: 32572658 Free PMC article. No abstract available.
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.
Gärtner J, Hauser SL, Bar-Or A, Montalban X, Cohen JA, Cross AH, Deiva K, Ganjgahi H, Häring DA, Li B, Pingili R, Ramanathan K, Su W, Willi R, Kieseier B, Kappos L. Gärtner J, et al. Among authors: cross ah. Mult Scler. 2022 Sep;28(10):1562-1575. doi: 10.1177/13524585221078825. Epub 2022 Mar 10. Mult Scler. 2022. PMID: 35266417 Free PMC article. Clinical Trial.
1,817 results